In allogenic hematopoietic stem cell transplantation, an effect of HLA locus mismatch in allele level on clinical outcome has been clarified. However, the effect of each HLA allele mismatch combination is little known, and its molecular mechanism to induce acute graft-versus-host disease (aGVHD) remains to be elucidated. Total 5210 donor-patient pairs transplanted through Japan Marrow Donor Program were analyzed.
Allogenic hematopoietic stem cell transplantation (HSCT) from a HLA matched unrelated (UR) donor has been established as a treatment for hematologic malignancies, when an HLA-identical sibling donor is unavailable. 1,2 When a matched unrelated donor was not found in the donor registry, a partially-HLA-matched unrelated donor was one of the candidates for alternative donor. But the higher risk of immunological events, especially graft-versus-host disease (GVHD), was an important drawback. Extensive recent research has accumulated evidences of the role of each HLA locus mismatch on clinical outcome for UR-HSCT, [3] [4] [5] [6] [7] [8] [9] which has made it easy to search and select a partially-matched donor. To further expand options for donor selection, our next challenge is to identify permissive and nonpermissive mismatch combinations of each HLA allele. Although there were some divisional trials with small populations, 10,11 a large-scale cohort is essential for comprehensive analysis to identify nonpermissive mismatch combinations that are significant risk factors for severe acute graft-versus-host disease (aGVHD).
In this study, we identified nonpermissive HLA mismatch allele combinations of all major six HLA loci, and their responsible positions of amino acid substitution for aGVHD.
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Patients, materials and methods

Patients
HLA typing of patients and donors
Alleles at the HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1 loci were identified by the methods described previously. 4, 5 Six HLA locus alleles were typed in all 5210 pairs.
HLA genotypes of HLA-A, -B, -C, -DQB1 and -DPB1 allele of patient and donor were reconfirmed by the Luminex microbead method (Luminex 100 System, Luminex, Austin, TX). For convenience, we showed the frequency of HLA alleles which existed with more than a 5% allele frequency in the current Japanese data set and less than a 1%
allele frequency in Caucasian populations 12 in Supplementary Table 2 .
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Matching of HLA allele between patient and donor
For the analysis of aGVHD, HLA allele mismatch among the donor-recipient pair was scored when the recipient's alleles were not shared by the donor (GVH vector). We also used GVH vectors for the analysis of overall survival (OS) to indicate OS of aGVHD high-risk or low-risk group.
Evaluation of acute GVHD
Occurrences of aGVHD were graded with grade 0, I, II, III and IV according to established criteria. 13 Grades III and IV were defined as severe aGVHD.
Definitions of amino acid substitution
Amino acid sequences of HLA-A, -B, -C, -DR, -DQ and DP molecules were obtained from IMGT/HLA sequence database on the web site (http://www.ebi.ac.uk/imgt/hla/).
For example, Tyr9A-Phe9A indicated amino acid substitutions of position 9 in HLA-A molecule at which the donor had tyrosine and the patient phenylalanine. Substituted amino acids in HLA class I were summarized in supplementary Tables 3-5 .
Definition of nonpermissive HLA combinations
We defined the nonpermissive HLA allele combination as a significant risk factor for severe aGVHD, because severe aGVHD was a solid marker for alloreactivity in HSCT and was the main contributor to transplant-related mortality.
14,15
For
Definition of hydropathy scale
The hydropathy scale proposed by Kyte and Doolittle 16 evaluates the hydrophilicity and hydrophobicity of 20 amino acids to estimate the protein structure. Hydrophobic amino acid has a plus value and hydrophilic amino acid a minus value, and their absolute value indicates the grade of each property.
Statistical analysis
Cumulative incidences of aGVHD were assessed by the method described elsewhere to eliminate the effect of competing risk. 17, 18 The competing event regarding aGVHD was defined as death without aGVHD. A logrank test was applied to assess the impact by the factor of interest. Multivariable Cox regression analyses 19 were conducted to evaluate the impact of HLA allele mismatch combination, and the positions and types of amino acid substitution (for example, alanine, arginine, asparagines, etc.) of HLA molecules.
The HLA mismatch combination was evaluated for each locus separately, and the HLA match and HLA one-locus mismatch in every locus were analyzed. For example, A0206-A0201 mismatch combination meant that the donor has HLA-A*0206, recipient has HLA-A*0201 and another HLA-A allele of each donor and recipient was identical.
This mismatch was compared with the HLA-A allele match. The mismatch combination of which the number of pairs was less than ten was lumped together as "other mismatch." This is because, according to the computer simulation by Peduzzi et al., 20 it is generally accepted that regression analysis for variable having less than 10 events might give an unreliable estimation. The model was constructed with mismatch The impact of positions and types of amino acid substitution in HLA molecules was evaluated in pairs with HLA one-locus mismatch in HLA-A, -B, -C, -DRB1, -DQB1
and -DPB1 separately. The amino acid positions we analyzed were all those at which amino acid was substituted in each locus. We analyzed the impact of each amino acid substitution on each position separately. Multivariable Cox models including positions and types of amino acid substitution, mismatch status in other loci (match, 1 locus mismatch and 2 locus mismatches as ordinal variable) and confounders described above were constructed.
We applied a P value of less than 0.005 as statistically significant to eliminate false positive associations. All the analyses were conducted by STATA version 9.2 (Stata Corp., College Station, TX).
Validation of statistical analysis
We validated the statistical analysis using two methods, traditional training-and-test method and bootstrap resampling method, in HLA-A analysis to confirmed the usability When consistent results were obtained in both analyses, we considered the results as validated. In the bootstrap resampling method, 21 we estimated the measure of association with the re-sampled data repeatedly drawn from the original data. Although around 100 to 200 bootstrapped samplings are generally sufficient, 22 we explored 500, 1000, 5000, 10000 and 50000 bootstrappings in analysis of HLA-A mismatch combinations. We confirmed that an analysis using more than 5000 bootstrappings made the results stable. Because there was high concordance between these two methods (Supplementary Table 6 ), we adopted bootstrap resampling using 10000 bootstrap samples for all analyses in this paper as the method for validation. This is because traditional training-and-test method do not work efficiently when small subgroups are considered as in this paper. Only when the results of base analysis and validating analysis using bootstrap resampling were significant concurrently, the results of the analysis judged to be statistically significant. When the result of base analysis was significant but the result of validating analysis using bootstrap resampling was not, we indicated this by adding an asterisk next to the P value of the base analysis.
RESULTS
Impact of HLA Allele mismatch combinations on severe aGVHD
Hazard ratios (HR) of HLA allele mismatch combinations in HLA-A and -C on severe aGVHD are shown in Table 2 (HLA-B, -DR, -DQ and -DP are available as supplementary Table 7 ). and one HLA-DRB1-DQB1 linked mismatch combination (see Table 2 Table 3 . The curve of cumulative incidence of severe aGVHD is shown in Figure 1A . Multivariable analysis revealed that severe aGVHD occured with almost equal frequency between the Full match group and Zero nonpermissive mismatch group, and was significantly associated with the number of nonpermissive mismatches (Table 4 ). Relative risk of significant factor for aGVHD and OS is shown in supplementary Table 8 . In terms of the mortality due to aGVHD according to the number of nonpermissive mismatches, One nonpermissive mismatch group and Two or more nonpermissive mismatch groups showed higher mortality (19.7% and 15.8% respectively) than Full match group and Zero nonpermissive mismatch group (8.5% and 11.4% respectively).
Impact of positions and types of amino acid substitutions of HLA molecules for severe aGVHD
One specific amino acid substitution at position 9 in HLA-A molecule and six specific amino acid substitutions at positions 9, 77, 80, 99, 116 and 156 in HLA-C molecule were significant risk factors for severe aGVHD: Tyr9A-Phe9A Table 5 
Discussion
Extensive recent research has accumulated evidences of the role of each HLA locus mismatch on clinical outcome for UR-HSCT. [3] [4] [5] [6] [7] [8] [9] Our next concern is identifying the combinations of HLA allele mismatch and the positions of amino acid substitution of the HLA molecules responsible for aGVHD. In the present study, multivariable analysis revealed that 15 combinations of HLA allele mismatch and one HLA-DRB1-DQB1
haplotype mismatch significantly increase the occurrence of severe aGVHD (Table 2) , and most of them increased the mortality rate after transplantation (data not shown).
Thus, these mismatch combinations of HLA allele might be called nonpermissive clinically. We speculated that the effect of HLA locus mismatch was a reflection and summation of these HLA allele mismatch combinations. Discrepancies of responsible HLA locus for aGVHD between ethnically-diverse transplantations might be explained by the proportions of non-permissive mismatch combinations in each HLA locus. The same study in other populations would be needed to clarify this question as well as the severity of aGVHD. Interestingly, the Full match group and Zero nonpermissive mismatch group showed an almost equal occurrence of severe aGVHD, though pairs in Zero nonpermissive mismatch group had one or more mismatches other than nonpermissive mismatches. And HR was elevated with the increase in the number of nonpermissive mismatches ( Figure 1A ; Table 4 ), while the number of nonpermissive mismatches also had a significant effect on OS after transplantation ( Figure 1B ; Table   4 ). These findings indicated at least that nonpermissive mismatches should be avoided in donor selection for UR-HSCT, and that the order of donor selection based on this nonpermissive mismatch would be useful, instead of that based on HLA locus mismatch.
We also speculated that there are permissive mismatches in mismatches other than nonpermissive mismatches. It is therefore an important task in the future to identify permissive mismatches for partially-HLA-matched donor selection. On the other hand, In this study, substitutions of specific amino acids at positions 9, 77, 80, 99, 116 and 156 were elucidated as a significant risk factor for severe aGVHD. We speculated that the responsibility of positions 77 and 80 in HLA-C for severe aGVHD was associated with ligand matching of NK cell receptor (KIR2DL). Although the role of KIR2DL in acute GVHD has been controversial, 24 a recent JMDP analysis demonstrated that To our knowledge, amino acid substitutions at positions 9 (Tyr9A-Phe9A and Tyr9C-Ser9C) and position 99 (Tyr99C-Phe99C) were newly identified in the present study as responsible for severe aGVHD.
Ferrara et al. reported that the amino acid substitution at position 116 in HLA class I molecule increased the risk for aGVHD, although the substituted amino acid was not taken into consideration. 28 In our study, specific amino acid substitution at position 116 had a significant effect in HLA-C (Leu116C-Ser116C) and a marginal effect in HLA-A (Asn116A-Asp116A) for severe aGVHD (Table 5 ).
For personal use only. on May 4, 2017. by guest www.bloodjournal.org From 1 5 Position 156 of HLA molecule was certified to modify T cell alloreactivity in vitro in HLA-A2, [29] [30] [31] HLA-B35 32 and HLA-B44. 23 For example, in contrast to Asp156B in HLA-B*4402, the non-polar nature of substituted Leu156B in HLA-B*4403 lost many interactions such as hydrogen bonds and van der Waals interactions with the other amino acid residues which constructed binding pockets. As a result, this substitution made the significant conformation change for alloreactivity. 23 In the HLA-B*3501 and HLA-B*3508 combination, Leu156B in HLA-B*3501 with non-polar residue was substituted for Asp156B in HLA-B*3508 with polar residue, and induced strong alloreactivity. 32 In our study, the magnitude of the polar change of each substituted amino acid was calculated by "hydropathy scale," 16 because the influence of this scale on the amino acid interaction was much greater than the influence of the isoelectric point. 33 Specific amino acid substitutions at position 9, 99, 116 and 156, which were not associated with KIR2DL ligand, were found to induce great polar changes except for Tyr9C-Ser9C. Generally speaking, the three major physicochemical properties of amino acids which play important roles in protein structure are the hydropathy scale, isoelectric point and molecular weight, and molecular weight is reflected in the size of amino acids. 33 Indeed, although tyrosine and serine in Tyr9C-Ser9C show little differences in hydropathy scale and isoelectric point, their molecular weights are quite different and may well induce an important conformation change in the HLA molecule.
Thus, the change in the conformation by the polar change of the HLA molecule might be one of the mechanisms inducing alloreactivity. These data serve to clarify the mechanisms of aGVHD based on the HLA molecule. For HR denotes hazard ratio and CI confidencel interval.
*Asterisk beside p value indicates that the result of base analysis was significant, but the result of validating analysis using bootstrap resampleing was not. The results of the analysis were thus judged not to be statistically significant. Arg156C-Leu156C 
